GLP-1 regulates calorie intake, GI motility and glucose homeostasis (36), and research suggests that it may be a novel treatment for NASH, as it exerts direct and beneficial effects on hepatocytes, preventing their progression from NAFLD to NASH (57, 58). The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.